 SAN DIEGO, Oct. 18, 2022 GLOBE NEWSWIRE -- Eterna Therapeutics Inc. Nasdaq: ERNA Eterna or the Company, a biopharmaceutical company using advanced cell engineering technology to develop transformational new medicines, today announced that Matt Angel, Ph.D., Interim Chief Executive Officer of Eterna, will present at the iPSC-Derived Immunotherapies Congress, taking place October 18-19, 2022 in Boston. 